Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
While protein therapeutics are indispensable in the treatment of a variety of diseases, including cancer, rheumatoid arthritis, and diabetes, key limitations including short half-lives, high immunogenicity, protein instability, and centralized production complicate long-term use and on-demand produc...
Main Author: | |
---|---|
Format: | Others |
Published: |
BYU ScholarsArchive
2018
|
Subjects: | |
Online Access: | https://scholarsarchive.byu.edu/etd/7713 https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8713&context=etd |
id |
ndltd-BGMYU2-oai-scholarsarchive.byu.edu-etd-8713 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-BGMYU2-oai-scholarsarchive.byu.edu-etd-87132020-07-15T07:09:31Z Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics Wilding, Kristen Michelle While protein therapeutics are indispensable in the treatment of a variety of diseases, including cancer, rheumatoid arthritis, and diabetes, key limitations including short half-lives, high immunogenicity, protein instability, and centralized production complicate long-term use and on-demand production. Site-specific polymer conjugation provides a method for mitigating these challenges while minimizing negative impacts on protein activity. However, the location-dependent effects of polymer conjugation are not well understood. Cell-free protein synthesis provides direct access to the synthesis environment and rapid synthesis times, enabling rapid evaluation of multiple conjugation sites on a target protein. Here, work is presented towards developing cell-free protein synthesis as a platform for both design and on-demand production of next generation polymer-protein therapeutics, including (1) eliminating endotoxin contamination in cell-free reagents for simplified therapeutic preparation, (2) improving shelf-stability of cell-free reagents via lyophilization for on-demand production, (3) coupling coarse-grain simulation with high-throughput cell-free protein synthesis to enable rapid identification of optimal polymer conjugation sites, and (4) optimizing cell-free protein synthesis for production of therapeutic proteins 2018-12-01T08:00:00Z text application/pdf https://scholarsarchive.byu.edu/etd/7713 https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8713&context=etd http://lib.byu.edu/about/copyright/ Theses and Dissertations BYU ScholarsArchive synthetic biology cell-free protein synthesis endotoxin removal lyophilization lyoprotectant unnatural amino acid high-throughput screening Engineering |
collection |
NDLTD |
format |
Others
|
sources |
NDLTD |
topic |
synthetic biology cell-free protein synthesis endotoxin removal lyophilization lyoprotectant unnatural amino acid high-throughput screening Engineering |
spellingShingle |
synthetic biology cell-free protein synthesis endotoxin removal lyophilization lyoprotectant unnatural amino acid high-throughput screening Engineering Wilding, Kristen Michelle Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics |
description |
While protein therapeutics are indispensable in the treatment of a variety of diseases, including cancer, rheumatoid arthritis, and diabetes, key limitations including short half-lives, high immunogenicity, protein instability, and centralized production complicate long-term use and on-demand production. Site-specific polymer conjugation provides a method for mitigating these challenges while minimizing negative impacts on protein activity. However, the location-dependent effects of polymer conjugation are not well understood. Cell-free protein synthesis provides direct access to the synthesis environment and rapid synthesis times, enabling rapid evaluation of multiple conjugation sites on a target protein. Here, work is presented towards developing cell-free protein synthesis as a platform for both design and on-demand production of next generation polymer-protein therapeutics, including (1) eliminating endotoxin contamination in cell-free reagents for simplified therapeutic preparation, (2) improving shelf-stability of cell-free reagents via lyophilization for on-demand production, (3) coupling coarse-grain simulation with high-throughput cell-free protein synthesis to enable rapid identification of optimal polymer conjugation sites, and (4) optimizing cell-free protein synthesis for production of therapeutic proteins |
author |
Wilding, Kristen Michelle |
author_facet |
Wilding, Kristen Michelle |
author_sort |
Wilding, Kristen Michelle |
title |
Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics |
title_short |
Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics |
title_full |
Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics |
title_fullStr |
Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics |
title_full_unstemmed |
Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics |
title_sort |
engineering cell-free biosystems for on-site production and rapid design of next-generation therapeutics |
publisher |
BYU ScholarsArchive |
publishDate |
2018 |
url |
https://scholarsarchive.byu.edu/etd/7713 https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8713&context=etd |
work_keys_str_mv |
AT wildingkristenmichelle engineeringcellfreebiosystemsforonsiteproductionandrapiddesignofnextgenerationtherapeutics |
_version_ |
1719325232694558720 |